On-Demand Webinar: Novel High-Throughput Glycoanalytics for Biopharmaceuticals

As industry-wide advancements in antibody drug discovery continue to push toward larger panels of candidates for early-stage characterization, more efficient identification of lead molecules through enhanced screening resolution is required. Integrating instruments like the Octet^® into the overall characterization workflow enables reliable, high throughput selection of lead candidates more effectively than alternative traditional techniques. This presentation will highlight a few unique methods of Octet^® utilization as a replacement or supplemental tool for various antibody discovery protocols. Comparisons across platforms, including traditional ELISA, flow cytometry, surface plasmon resonance, and in vivo studies will be presented.

Webinar Duration: 38 minutes

Webinar Speakers:

Victoria Smith, PhD, Principal Scientist | CPI Biologics
Lewis Wharram, Analytical Scientist | CPI Biologics

Learning Objectives

Improve the overall drug discovery process to increase the success rate of preclinical candidates
Identify elite candidates earlier in screening
Use of the Octet^® platform in high-throughput, high-resolution screening for selection of lead candidates